SMAD3 and posterior cortical atrophy: Chromatin immunoprecipitation (ChIP) analysis was performed and revealed that SMAD3 was preferentially enriched at the SPOP promoter under the treatment of TGF-β, which was significantly reduced when PCa cells were treated with SB431542 (Figure 3B and 3C).